Amicus Therapeutics, Inc. (NASDAQ:FOLD) reported 12/31/2018 earnings this Morning, coming in at ($0.41) per share, missing Wall Street’s estimates of ($0.28) per Share. Revenue for the quarter came in at $32.64 million beating analyst estimates of $30.81 million
Story continues below
Recent Trading for Amicus Therapeutics, Inc. (NASDAQ:FOLD)
Shares of Amicus Therapeutics, Inc. closed the previous trading session at 12.25 −0.18 1.45% with 12.57 shares trading hands.
An ad to help with our costs